1+ day, 12+ hour ago   (230+ words) Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer Key efficacy results from the phase III TAISHAN-302 trial1 Tam-Peli is designed to target B7-H3, a protein broadly expressed…...

3+ day, 23+ hour ago   (280+ words) Connected datasets provide a 360° view of the patient NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Citeline, a Norstella company and leading provider of clinical, drug and commercial intelligence for the life sciences industry, introduces Patient Intelligence, providing a complete view of the…...

5+ day, 16+ hour ago   (121+ words) Inventiva to Present Multiple Abstracts at Paris MASH 2026 Lanifibranor is currently being evaluated in the Phase 3 NATiV3 clinical trial for the treatment of patients with MASH with moderate and advanced fibrosis, with topline results expected in the fourth quarter of this…...

6+ day, 6+ hour ago   (417+ words) Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial OXFORD, United Kingdom, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Greywolf Therapeutics, the clinical-stage biotech company advancing novel antigen modulation treatments for cancer and autoimmune diseases, today reports significant progress in their Phase…...

6+ day, 7+ hour ago   (77+ words) Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1) LEADING EDGE MATERIALS DRILLS NEAR-MINE TO TEST FOR A LARGER REGIONAL GRAPHITE SYSTEM AT WOXNA, SWEDEN PRESS RELEASE: CMB.TECH announces special…...

1+ week, 5+ day ago   (237+ words) Research Team Wins Heinz Maurer Award for Linking Bacterium to Eczema Barrier Failure The team combined lipidomics, profiling the fatty molecules forming the skin's outermost layer, with microbiome profiling, identifying bacterial communities on the skin's surface. Both were performed on…...

1+ week, 6+ day ago   (436+ words) Medicel AG expands its SOFT TIP I/A portfolio with the launch of BICEL™ SOFT TIP I/A terralution™ – bimanual sustainable I/A (irrigation / aspiration) for gentle tissue interaction – at the ESCRS Congress 2026 in London. ALTENRHEIN, Switzerland, Sept. 01, 2026 (GLOBE NEWSWIRE)…...

2+ week, 4+ hour ago   (309+ words) Under a partnership with Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Alvotech is responsible for the development and manufacturing of AVT80, while Teva is responsible for commercialization. “FDA’s acceptance for review of our BLA for AVT80 is another important milestone for…...

2+ week, 4+ hour ago   (183+ words) XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation LOS ALTOS, California, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Open-label, dose-escalation study using cardiac rhythm data from implantable and wearable AF monitors allows…...

2+ week, 5+ day ago   (261+ words) Through the collaboration, Genezen will offer access to 4basebio’s synthetic DNA developed specifically for viral vector applications, creating a more streamlined path for cell and gene therapy developers to advance programs toward the clinic. The cell-free manufacturing approach can also…...